Form 4 for JSPR Jasper Therapeutics, Inc.
Accepted 2023-06-13 00:00:00 ET · period of report 2023-06-13 · accession 0001213900-23-048683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-13 | 2023-06-13 | JSPR | Mahal Jeetinder Singh | See Remarks | S - Sale+OE | $1.66 | -9,000 | 287.2K | -3% | -$14.9K |
| D | 2023-06-13 | 2023-06-13 | JSPR | Mahal Jeetinder Singh | See Remarks | M - OptEx | $0.71 | +9,000 | 296.2K | +3% | +$6,390 |
| D | 2023-06-13 | 2023-06-13 | JSPR | Mahal Jeetinder Singh | See Remarks | M - OptEx | $0.00 | +9,000 | 173.7K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2023-06-13 | S | D | 9,000 | $1.66 | 287,223 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Voting Common Stock | 2023-06-13 | M | A | 9,000 | $0.71 | 296,223 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-06-13 | M | A | 9,000 | $0.00 | 173,713 | D | $0.71 · — to 2030-05-31 | 9,000 Voting Common Stock | (F3) 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |